Long Term Followup of Patients Enrolled in MC1137 (BEAUTY)

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Procedure, Other
Study Type: Observational
SUMMARY

This study gathers information and samples for further analysis as part of the BEAUTY study. The purpose of the BEAUTY study was to better understand the reasons why or why not breast cancers respond to standard chemotherapy. Collecting samples of blood and tissue and health and treatment information from patients on the BEAUTY study may help doctors identify changes that make cancer better respond to standard chemotherapy and develop better therapies for the treatment of cancer.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• REGISTRATION - FOR PATIENTS STILL ALIVE:

• Enrolled in BEAUTY \[MC1137 (NCT02022202)\] and did not withdraw consent while enrolled on BEAUTY for either specimen collection or long-term follow-up

• Able to provide written informed consent

• REGISTRATION - FOR PATIENTS WHO HAVE DIED:

• Enrolled in MC1137 and did not withdraw consent while enrolled on BEAUTY for either specimen collection or long-term follow-up

• Existence of a family member willing to provide consent for use of archived tumor biopsies obtained after enrollment in BEAUTY

Locations
United States
Arizona
Mayo Clinic in Arizona
RECRUITING
Scottsdale
Florida
Mayo Clinic in Florida
RECRUITING
Jacksonville
Minnesota
Mayo Clinic in Rochester
RECRUITING
Rochester
Contact Information
Primary
Clinical Trials Referral Office
mayocliniccancerstudies@mayo.edu
855-776-0015
Time Frame
Start Date: 2023-01-27
Estimated Completion Date: 2033-12-31
Participants
Target number of participants: 140
Treatments
Observational (biospecimen collection, questionnaire)
Patients undergo collection of blood samples throughout the study. Patients may also complete questionnaires and undergo the collection of tissue samples throughout the study.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov